Bendamustine-based first line therapy in chronic lymphocytic leukemia (CLL) in treatment routine: Interim results of the non-interventional study Be-CeLL1st. 6. Juni 2014 Ruffert, K., Aldaoud, A., Klausmann, M., Bruch, H.-R., Hansen, R., Losem, C., Frank, M., Straßl, L., 2014. Oncol Res Treat 37(suppl 5)(P194), 53–54. doi:10.1159/000368945 Abstract Interim analysis of a non-interventional study evaluating the quality of life in second-line treatment of metastatic renal cell carcinoma with everolimus (EVERPRO). Bergmann, L., Goebell, P., Kloß, S., Schirrmacher-Memel, S., Warnack, W., Kube, U., Scheffler, M., Doehn, C., Marschner, N., Rosé, C., Herrmann, E., 2014. Oncol Res… Weiterlesen Bendamustine-based first line therapy in chronic lymphocytic leukemia (CLL) in routine clinical practice: Interim analysis of the German non-interventional study Be-CeLL1st. Bruch, H.-R., Aldaoud, A., Klausmann, M., Hansen, R., Losem, C., Frank, M., Straßl, L., Ruffert, K., 2014. Haematologica 99 (suppl 1) (PB1504). Weiterlesen